Acquired coagulation inhibitor-associated bleeding disorders: An update

Hematology

Volumn 10, Issue 6, 2005, Pages 443-449

  Franchini, Massimo ^a   Veneri, Dino ^b  

^a UNIVERSITY HOSPITAL OF VERONA   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

Author keywords

Acquired; Bleeding; Hemophilia; Inhibitors; Treatment

Indexed keywords

AZATHIOPRINE; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 ANTIBODY; BLOOD CLOTTING FACTOR 9; BLOOD CLOTTING INHIBITOR; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DESMOPRESSIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; MERCAPTOPURINE; PREDNISONE; VINCRISTINE; VON WILLEBRAND FACTOR;

ANTIBODY TITER; DISEASE SEVERITY; HEMOPHILIA A; HUMAN; INCIDENCE; LABORATORY DIAGNOSIS; MORTALITY; PARTIAL THROMBOPLASTIN TIME; POPULATION DISTRIBUTION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; VON WILLEBRAND DISEASE;

AUTOANTIBODIES; BLOOD COAGULATION DISORDERS; BLOOD COAGULATION FACTORS; HEMOPHILIA A; HUMANS;

EID: 31144459782     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1080/10245330500276642     Document Type: Review

References (122)

1. Cohen, AJ and Kessler, CM. (1996) Acquired inhibitors Bailleres Clin Haematol, 9, pp. 331-354.
2. Watson, HG and Chee, Y-L and Greaves, M. (2001) Rare acquired bleeding disorders Rev Clin Exp Hematol, 5, pp. 405-429.
3. Bouvry, P and Recloux, P. (1994) Acquired hemophilia Haematologica, 79, pp. 550-556.
4. Morrison, AE. (1995) Acquired haemophilia and its management Br J Haematol, 89, pp. 231-236.
5. Vivaldi, P and Savino, M and Mazzon, C and Rubertelli, M. (1993) A hemorrhagic syndrome of the elderly patient caused by anti-factor VIII antibodies Haematologica, 78, pp. 245-248.
6. Hay, CRM. (1998) Acquired haemophilia Bailleres Clin Haematol, 11, pp. 287-303.
7. Sultan, Y. (1997) Acquired hemophilia and its treatment Blood Coagul Fibrinolysis, 8(1), pp. 15S-18S.
8. Boggio, LN and Green, D. (2001) Acquired hemophilia Rev Clin Exp Hematol, 5, pp. 389-404.
9. Pruthi, RK and Nichols, WL. (1999) Autoimmune factor VIII inhibitors Curr Opin Hematol, 6, pp. 314-322.
10. Hay, CRM and Baglin, TP and Collins, PW and Hill, FGH and Keeling, DM. (2000) The diagnosis and management of factor VIII and IX inhibitors: A guideline from the UK Haemophilia Centre Doctors' Organization (UKHCDO) Br J Haematol, 111, pp. 78-90.
11. Delgado, J and Yimenez-Yuste, V and Hernandez-Navarro, F and Villar, A. (2003) Acquired haemophilia: Review and meta-analysis focused on therapy and prognostic factors Br J Haematol, 121, pp. 21-35.
12. Green, D and Blanc, J and Foiles. (1999) Spontaneous inhibitors of factor VIII: Kinetics of inactivation of human and porcine factor VIII J Lab Clin Med, 133, pp. 260-264.
13. Lacroix-Desmazes, S and Sooryanarayana and Moreau, A and Kazatchkine, MD and Kaveri, SV. (2000) Factor VIII inhibitor with catalytic activity towards factor VIII Haematologica, 85, pp. 89-92.
14. Kazatchkine, MD and Lacroix-Desmazes, S and Moreau, A and Kaveri, SV. (2000) Idiotypic regulation of anti-factor VIII antibodies Haematologica, 85, pp. 97-99.
15. Green, D and Lechner, K. (1981) A survey of 215 non-hemophilic patients with inhibitors to factor VIII Thromb Haemost, 45, pp. 200-203.
16. Lottenberg, R and Kentro, TB and Kitchens, CS. (1987) Acquired hemophilia. A natural history study of 16 patients with factor VIII inhibitors receiving little or no therapy Arch Intern Med, 147(1077), pp. 1081.
17. Bossi, P and Cabane, J and Ninet, J and (1998) Acquired haemophilia due to factor VIII inhibitors in 34 patients Am J Med, 105, pp. 400-408.
18. Yee, TT and Pasi, KJ and Lilley, PA and Lee, CA. (1999) Factor VIII inhibitors in haemophiliacs: A single-centre experience over 34 years, 1964-1997. Br J Haematol, 104:909-914.
19. Yee, TT and Taher, A and Pasi, KJ and Lee, CA. (2000) A survey of patients with acquired hemophilia in a hemophilia centre over a 28-year period Clin Lab Haem, 22, pp. 275-278.
20. Baudo, F and de Cataldo, F. (2002) Acquired factor VIII and IX inhibitors: Survey of the Italian Haemophilia Centers (AICE). Register of acquired factor VIII/IX inhibitors Haematologica, 87, pp. 22-28.
21. Baudo, F and de Cataldo, F. (20042004) Acquired hemophilia: A critical bleeding syndrome Haematologica, 89, pp. 96-100.
22. Morrison, AE and Ludlam, CA and Kessler, C. (1993) Use of porcine factor VIII in the treatment of patients with acquired hemophilia Blood, 81, pp. 1513-1520.
23. Hay, CRM and Negrier, C and Ludlam, CA. (1997) The treatment of bleeding in acquired hemophilia with recombinant factor VIIa: A multicenter study Thromb Haemost, 78, pp. 3-7.
24. Godreuil, S and Navarro, R and Quittet, P and Landreau, L and Schved, JF and Biron-Andreani, C. (2001) Acquired haemophilia in the elderly is a severe disease: Report of five new cases Haemophilia, 7, pp. 428-432.
25. Solymoss, S. (1998) Postpartum acquired factor VIII inhibitors: Results of a survey Am J Haematol, 59, pp. 1-4.
26. Kashyap, R and Choudhry, VP and Mahapatra, M and Chumber, S and Saxena, R and Kaul, HL. (2001) Postpartum acquired haemophilia: Clinical recognition and management Haemophilia, 7, pp. 327-330.
27. Mazzucconi, MG and Bizzoni, L and Giorgi, A and (2001) Postpartum inhibitor to factor VIII: Treatment with high-dose immunoglobulin and dexamethasone Haemophilia, 7, pp. 422-427.
28. Hauser, I and Schneider, B and Lechner, K. (1995) Post-partum factor VIII inhibitors: A review of the literature with special reference to the value of steroid and immunosuppressive treatment Thromb Haemost, 73, pp. 1-5.
29. Kadir, RA and Koh, MB and Lee, CA and Pasi, KJ. (1997) Acquired haemophilia, an unusual cause of severe postpartum haemorrhage Br J Obstet Gynaecol, 104, pp. 854-856.
30. Baudo, F and de Cataldo, F. (2003) Acquired factor VIII inhibitors in pregnancy: Data from the Italian haemophilia register relevant to clinical practice BJOG, 110, pp. 311-314.
31. Soriano, RM and Mathews, JM and Guerado-Parra, E. (1987) Acquired haemophilia and rheumatoid arthritis Br J Rheumatol, 26, pp. 381-383.
32. Vignes, S and Le Moing, V and Meekel, P and Papo, T and Wechsler, B and Godeau, P. (1996) Acquired hemophilia: A rare complication of Sjögren's syndrome Clin Exp Rheumatol, 14, pp. 559-560.
33. Meiklejohn, DJ and Watson, HG. (2001) Acquired haemophilia in association with organ-specific autoimmune disease Haemophilia, 7, pp. 523-525.
34. Sievert, R and Goldestein, ML and Surks, MI. (1996) Graves' disease and autoimmune factor VIII deficiency Thyroid, 6, pp. 245-247.
35. Sallah, S and Nguien, NP and Abdallah, JM and Hanrahan, LR. (2000) Acquired hemophilia in patients with hematologic malignancies Arch Pathol Lab Med, 124, pp. 730-734.
36. Sallah, S and Singh, P and Hanrahan, LR. (1998) Antibodies against factor VIII in patients with solid tumors: Successful treatment of cancer may suppress inhibitor formation Haemostasis, 28, pp. 244-249.
37. Sallah, S and Wan, JY. (2001) Inhibitors against factor VIII in patients with cancer Cancer, 91, pp. 1067-1074.
38. Sohngen, D and Specker, C and Bach, D and (1997) Acquired factor VIII inhibitors in nonhemophilic patients Ann Hematol, 74, pp. 89-93.
39. Hultin, MB. (1991) Acquired inhibitors in malignant and nonmalignant disease states Am J Med, 91, pp. 9-13.
40. O'Reilly, RA and Hamilton, RD. (2002) Acquired haemophilia, meningioma and diphenylhydantoin therapy J Neurosurg, 53, pp. 600-605.
41. Ferri, GM and Vaccaro, F and Caccavo, D and Imperato, G and Bonomo, L. (1996) Development of factor VIII: C inhibitors following vaccination Acta Haematol, 96, pp. 110-111.
42. Sallah, S and Wan, JY. (2001) Inhibitors against factor VIII associated with the use of interferon-alpha and fludarabine Thromb Haemost, 86, pp. 1119-1121.
43. Mauser-Bunschoten, EP and Damen, M and Reesink, HW and Roosendal, G and Chamuleau, RA and van der Berg, HM. (1996) Formation of antibodies to factor VIII in patients with hemophilia A who are treated with interferon for chronic hepatitis C Ann Intern Med, 125, pp. 297-299.
44. Tiplady, CW and Hamilton, PJ and Galloway, MJ. (2000) Acquired haemophilia complicating the remission of a patient with high grade non-Hodgkin's lymphoma treated by fludarabine Clin Lab Haematol, 22, pp. 163-165.
45. Dentale, N and Fulgaro, C and Guerra, L and Fasulo, G and Mazzetti, M and Fabbri, C. (1997) Acquisition of factor VIII inhibitor after acute hepatitis C virus infection Blood, 90, pp. 3233-3234.
46. Blatt, PM and White, McMIll, II GC and an, CW and Roberts, HR. (1977) Treatment of antifactor VIII antibodies Thromb Haemost, 38, pp. 514-523.
47. Kasper, CK. (1989) The therapy of factor VIII inhibitors Prog Hemost Thromb, 33, pp. 57-86.
48. Ludlam, CA and Morrison, AE and Kessler, C. (1994) Treatment of acquired hemophilia Semin Hematol, 31, pp. 16-19.
49. Kessler, CM. (2000) Acquired factor VIII autoantibody inhibitors: Current concept and potential therapeutic strategies for the future Haematologica, 85(10), pp. 57-63.
50. Delgado, J and Villar, A and Jimenez-Yuste, V and Gago, J and Quintana, M and Hernandez-Navarro, F. (2002) Acquired hemophilia: A single-center survey with emphasis on immunotherapy and treatment-related side-effects Eur J Haematol, 69, pp. 158-164.
51. Ingerslev, J. (2000) Strategies for the treatment of inhibitor patients Haematologica, 85, pp. 15-20.
52. Mudad, R and Kane, WH. (1993) DDAVP in acquired haemophilia A: Case report and review of the literature Am J Haematol, 43, pp. 295-299.
53. Gandini, G and Franchini, M and Manzato, F and Lippi, G and Aprili, G. (1999) A successful combination of prednisone, high-dose intravenous immunoglobulin and desmopressin in the treatment of acquired haemophilia A with high-titer inhibitor Haematologica, 84, pp. 1054.
54. Kessler, CM and Ludlam, CA. (1993) The treatment of acquired factor VIII inhibitors: World-wide experience with porcine factor VIII concentrate Semin Hematol, 30, pp. 22-27.
55. Hay, CRM and Bolton-Maggs, P. (1991) Porcine factor VIIIC in the management of patients with factor VIII inhibitors Trans Med Rev, 5, pp. 145-151.
56. Charles, RMH. (2000) Porcine factor VIII: Past, present and future Haematologica, 85, pp. 21-25.
57. Hilgartner, MW and Knatterud, GL. (1983) Feiba Study Group. The use of factor eight inhibitor by-passing activity (FEIBA Immuno) product for treatment of bleeding episodes in hemophiliacs with inhibitors Blood, 61, pp. 36-40.
58. Sultan, Y and Loyer, F. (1993) In vitro evaluation of factor VIII-bypassing activity of activated prothrombin complex concentrate, and factor VIIa in the plasma of patients with factor VIII inhibitors: Thrombin generation test in the presence of collagen-activated platelets J Lab Clin Med, 121, pp. 444-452.
59. Barthels, M. (1999) Clinical efficacy of prothrombin complex concentrates and recombinant factor VIIa in the treatment of bleeding episodes in patients with factor VIII and IX inhibitors Thromb Res, 95, pp. 31-38.
60. Hedner, U and Erhardtsen, E. (2002) Potential role for rFVIIa in transfusion medicine Transfusion, 42, pp. 114-124.
61. Liebman, HA and Chediak, J and Fink, KI and Galvez, AG and Shah, PC and Sham, RL. (2000) Activated recombinant human coagulation factor VII (rFVIIa) therapy for abdominal bleeding in patients with inhibitory antibodies to factor VIII Am J Hematol, 63, pp. 109-113.
62. Hay, CRM and Negrier, C and Ludlam, CA. (1997) The treatment of bleeding in acquired haemophilia with recombinant factor VIIa: A multicenter study Throm Haemost, 78, pp. 1463-1467.
63. Hedner, U. (1999) Treatment of patients with factor VIII and factor IX inhibitors with special focus on the use of recombinant factor VIIa Thromb Haemost, 82, pp. 531-539.
64. Hedner, U and Glazer, S and Falch, J. (1993) Recombinant activated factor VII in the treatment of bleeding episodes in patients with inherited and acquired bleeding disorders Transf Med Rev, 7, pp. 78-83.
65. Papadaki, HA and Xylouri, I and Valatas, W and Petinarakis, J and Kontopoulou, I and Eliopoulos, GD. (1997) Severe acquired hemophilia A successfully treated with activated recombinant human factor VII Ann Hematol, 77, pp. 123-125.
66. Franchini, M and Capra, F and Capelli, C and de Maria, E and Lippi, G and Gandini, G. (2001) Clinical efficacy of recombinant activated factor VII (rFVIIa) during acute bleeding episode and surgery in a patient with acquired hemophilia A with high inhibitor titer Haematologica, 86, pp. E12.
67. Sunagawa, T and Uezu, Y and Kadena, K and Tokuyama, K and Kinjo, F and Saito, A. (1999) Successful treatment of a non-haemophilic patient with inhibitor to factor VIII by double-filtration plasmapheresis Br J Haematol, 104, pp. 465-467.
68. Jansen, M and Schmaldienst, S and Banyai, S and Quehenberger, P and Pabinger, I and Derfler, K. (2001) Treatment of coagulation inhibitors with extracorporeal immunoadsorption (Ig-Therasorb) Br J Haematol, 112, pp. 91-97.
69. Guillet, B and Kriaa, F and Huisse, MG and Proulle, V and George, C and Tchernia, G. (2001) Protein A sepharose immunoadsorption: Immunological and haemostatic effects in two cases of acquired haemophilia Br J Haematol, 114, pp. 837-844.
70. Green, D. (1971) Suppression of an antibody to factor VIII by a combination of factor VIII and cyclophosphamide Blood, 37, pp. 381-387.
71. Shaffer, LG and Phillips, MD. (1997) Successful treatment of acquired hemophilia with oral immunosuppressive therapy Ann Intern Med, 127, pp. 206-209.
72. Green, D and Rademaker, AW and Briet, E. (1993) A prospective, randomized trial of prednisone and cyclophosphamide in the treatment of patients with factor VIII autoantibodies Thromb Haemost, 70, pp. 753-757.
73. Schwartz, RS and Gabriel, DA and Aledort, LM and Green, D and Kessler, CM. (1995) A prospective study of treatment of acquired (autoimmune) factor VIII inhibitors with high-dose intravenous gammaglobulin Blood, 86, pp. 797-804.
74. Schulman, S and Langevitz, P and Livneh, U and Mortinovitz, U and Seligsohn, U and Varon, D. (1996) Cyclosporine therapy for acquired factor VIII inhibitor in a patient with systemic lupus erythematosus Thromb Haemost, 76, pp. 344-346.
75. Petrovic, M and Derom, E and Baele, G. (2000) Cyclosporine treatment of acquired hemophilia due to factor VIII antibodies Haematologica, 85, pp. 895-896.
76. Schwedtfeger, R and Hintz, G and Huhn, G. (1991) Successful treatment of a patient with postpartum factor VIII inhibitors with recombinant human interferon alpha-2a Am J Hematol, 45, pp. 190-193.
77. Wiestner, A and Cho, HJ and Asch, AS and Michelis, MA and Zeller, JA and Peerschke, EIB. (2002) Rituximab in the treatment of acquired factor VIII inhibitor Blood, 100, pp. 3426-3428.
78. Nemes, L and Pitlik, E. (2000) New protocol for immune tolerance induction in acquired hemophilia Haematologica, 85, pp. 64-68.
79. Lu, L and Liu, Y and Wei, J and Zhang, L and Zhang, L and Yang, R. (2004) Acquired inhibitor of factor V: First report in China and literature review Haemophilia, 10, pp. 661-664.
80. Ortel, TL. (1999) Clinical and laboratory manifestations of anti-factor V antibodies J Lab Clin Med, 133, pp. 326-334.
81. Streiff, MB and Ness, PM. (2002) Acquired FV inhibitors: A needless iatrogenic complication of bovine thrombin exposure Transfusion, 42, pp. 18-26.
82. de Raucourt, E and Barbier, C and Sinda, P and Dib, M and Peltier, JY and Ternisien, C. (2003) High-dose intravenous immunoglobulin treatment in two patients with acquired factor V inhibitors Am J Hematol, 74, pp. 187-190.
83. Bayani, N and Rugina, M and Haddad-Vergnes, L and Lelong, F. (2002) High-titer acquired factor V inhibitor responsive to corticosteroids and cyclophosphamide in a patient with two malignant tumors Am J Hematol, 71, pp. 33-36.
84. Lian, EC and Tzakis, AG and Andrews, D. (2004) Response of factor V inhibitor to rituximab in a patient who received liver transplantation for primary biliary cirrhosis Am J Hematol, 77, pp. 363-365.
85. Castro, O and Farber, LR and Clyne, LP. (1972) Circulating anticoagulants against factors IX and XI in systemic lupus erythematosus Ann Intern Med, 77, pp. 543-548.
86. Largo, R and Sigg, P and von Felten, A and Straub, PW. (1974) Acquired factor-IX inhibitor in a nonhaemophilic patient with autoimmune disease Br J Haematol, 26, pp. 129-140.
87. Ozsoylu, S and Ozer, FL. (1973) Acquired factor IX deficiency. A report of two cases Acta Haematol, 50, pp. 305-314.
88. Abshire, T and Kenet, G. (2004) Recombinant factor VIIa: Review of efficacy, dosing regimens and safety in patients with congenital and acquired factor VIII or IX inhibitors J Thromb Haemost, 2, pp. 899-909.
89. Fukue, H and Anderson, K and McPhedran, P and Clyne, L and McDonagh, J. (1992) A unique factor XIII inhibitor to a fibrin-binding site on factor XIIIA Blood, 79, pp. 65-74.
90. Lorand, L and Maldonado, N and Fradera, J and Atencio, AC and Robertson, B and Urayama, T. (1972) Haemorrhagic syndrome of autoimmune origin with a specific inhibitor against fibrin stabilizing factor (factor XIII) Br J Haematol, 23, pp. 17-27.
91. Lorand, L and Velasco, PT and Murthy, SN and Lefebvre, P and Green, D. (1999) Autoimmune antibody in a hemorrhagic patient interacts with thrombin-activated factor XIII in a unique manner Blood, 93, pp. 909-917.
92. Daly, HM and Carson, PJ and Smith, JK. (1991) Intracerebral haemorrhage due to acquired factor XIII inhibitor-successful response to factor XIII concentrate Blood Coagul Fibrinolysis, 2, pp. 507-514.
93. Banninger, H and Hardegger, T and Tobler, A and et al. (1993) Fibrin glue in surgery: Frequent development of inhibitors of bovine thrombin and human factor V Br J Haematol, 85, pp. 528-532.
94. La Spada, AR and Skalhegg, BS and Henderson, R and Schmer, G and Pierce, R and Chandler, W. (1995) Brief report: Fatal hemorrhage in a patient with an acquired inhibitor of human thrombin N Engl J Med, 333, pp. 494-497.
95. Sie, P and Bezeaud, A and Dupouy, D and et al. (1991) An acquired antithrombin autoantibody directed toward the catalytic center of the enzyme J Clin Investig, 88, pp. 290-296.
96. Fleck, RA and Rapaport, SI and Rao, LV. (1988) Antiprothrombin antibodies and the lupus anticoagulant Blood, 72, pp. 512-519.
97. Galli, M and Barbui, T. (1999) Antithrombin antibodies: Detection and its significance in the antiphospholipid syndrome Blood, 92, pp. 2149-2157.
98. Bajaj, SP and Rapaport, SI and Barclay, S and Herbst, KD. (1985) Acquired hypoprothrombinemia due to non-neutralizing antibodies to prothrombin: Mechanism and management Blood, 65, pp. 1538-1543.
99. Williams, S and Williams, S and Linardic, C and Wilson, O and Comp, P and Gralnick, HR. (1996) Acquired hypoprothrombinemia: Effects of danazol treatment Am J Hematol, 53, pp. 272-276.
100. Holm, M and Andreasen, R and Ingerslev, J. (1999) Management of bleeding using recombinant factor VIIa in a patient suffering from bleeding tendency due to a lupus anticoagulant-hypoprothrombinemia syndrome Thromb Haemost, 82, pp. 1776-1778.
101. Campbell, E and Sanal, S and Mattson, J and Walker, L and Estry, S and Mueller, L and Schwarz, M. (1980) Hampton S Factor VII inhibitor Am J Med, 68, pp. 962-964.
102. Delmer, A and Horellou, MH and Andreu, G and (1989) Life-threatening intracranial bleeding associated with the presence of an antifactor VII autoantibody Blood, 74, pp. 229-232.
103. Goodrick, MJ and Prentice, AG and Copplestone, JA and Pamphilon, DH and Boon, RJ. (1992) Acquired factor XI inhibitor in chronic lymphocytic leukaemia J Clin Pathol, 45, pp. 352-353.
104. Rao, LV and Zivelin, A and Iturbe, I and Rapaport, SI. (1994) Antibody-induced acute factor X deficiency: Clinical manifestations and properties of the antibody Thromb Haemost, 72, pp. 363-371.
105. Smith, SV and Liles, DK and White, GC, 2nd and Brecher, ME. (1998) Successful treatment of transient acquired factor X deficiency by plasmapheresis with concomitant intravenous immunoglobulin and steroid therapy Am J Hematol, 57, pp. 245-252.
106. Mohri, H. (2003) Acquired von Willebrand syndrome: Its pathophysiology, laboratory features and management J Thromb Thrombolysis, 15, pp. 141-149.
107. Federici, AB and Rand, JH and Bucciarelli, P and (2000) Subcommittee on von Willebrand Factor. Acquired von Willebrand syndrome: Data from an international registry Thromb Haemost, 84, pp. 345-349.
108. Michiels, JJ and Michiels, JJ and Budde, U and (2001) Acquired von Willebrand syndromes: Clinical features, aetiology, pathophysiology, classification and management Best Pract Res Clin Haematol, 14, pp. 401-436.
109. Kumar, S and Pruthi, RK and Nichols, WL. (2003) Acquired von Willebrand's syndrome: A single institution experience Am J Hematol, 72, pp. 243-247.
110. Mannucci, PM and Lombardi, R and Bader, R and (1984) Studies of the pathophysiology of acquired von Willebrand's disease in seven patients with lymphoproliferative disorders or benign monoclonal gammopathies Blood, 64, 614-621.
111. Veyradier, A and Jenkins, CS and Fressinaud, E and Meyer, D. (2000) Acquired von Willebrand syndrome: From pathophysiology to management Thromb Haemost, 84, pp. 175-182.
112. Castaman, G and Rodeghiero, F and Di Bona, E and Ruggeri, M. (1989) Clinical effectiveness of desmopressin in a case of acquired von Willebrand's syndrome associated with benign monoclonal gammopathy Blut, 58, pp. 211-213.
113. Meyer, D and Frommel, D and Larrieu, MJ and Zimmerman, TS. (1979) Selective absence of large forms of factor VIII/von Willebrand factor in acquired von Willebrand's syndrome. Response to transfusion Blood, 54, pp. 600-606.
114. Meijer, K and Peters, FT and van der Meer, J. (2001) Recurrent severe bleeding from gastrointestinal angiodysplasia in a patient with von Willebrand's disease, controlled with recombinant factor VIIa Blood Coagul Fibrinolysis, 12, pp. 211-213.
115. Macik, BG and Gabriel, DA and White, GC, 2nd and High, K and Roberts, H and Macik, BG. (1988) The use of high-dose intravenous gamma-globulin in acquired von Willebrand syndrome Arch Pathol Lab Med, 112, pp. 143-146.
116. Greaves, M and Pickering, C and Porter, NR and Magee, JM and Preston, FE. (1983) Acquired Glanzmann's thrombasthenia Blood, 61, pp. 209.
117. Niessner, H and Clemetson, KJ and Panzer, S and Mueller-Eckhardt, C and Santoso, S and Bettelheim, P. (1986) Acquired thrombasthenia due to GPIIb/IIIa-specific platelet autoantibodies Blood, 68, pp. 571-576.
118. Devine, DV and Currie, MS and Rosse, WF and Greenberg, CS. (1987) Pseudo-Bernard-Soulier syndrome: Thrombocytopenia caused by autoantibody to platelet glycoprotein Ib Blood, 70, pp. 428-431.
119. Varon, D and Gitel, SN and Varon, N and et al. (1992) Immune Bernard Soulier-like syndrome associated with anti-glycoprotein-IX antibody Am J Hematol, 41, pp. 67-68.
120. Yanabu, M and Suzuki, M and Soga, T and et al. (1991) Influences of antiplatelet autoantibodies on platelet function in immune thrombocytopenic purpura Eur J Haematol, 46, pp. 101-106.
121. Malik, U and Dutcher, JP and Oleksowicz, L. (1998) Acquired Glanzmann's thrombasthenia associated with Hodgkin's lymphoma: A case report and review of the literature Cancer, 82, pp. 1764-1768.
122. Beales, JL. (1994) An acquired-pseudo Bernard Soulier syndrome occurring with autoimmune chronic active hepatitis and anti-cardiolipin antibody Postgrad Med J, 70, pp. 305-308.